News

Press Releases

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care

Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

Subscribe for News & Updates

* indicates required
Quick Links

Home

About Us

Contact

News

Projects

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™

Contact Us